 e  n  t  i  f  i  e  d  1  1  1  p  o  s  i  t  i  v  e  a  n  d  1  4  3  n  e  g  a  t  i  v  e  r  e  g  u  l  a  t  o  r  s  o  f  N  F  -κB  i  n  t  o  t  a  l  f  r  o  m  t  h  e  2  d  i  f  f  e  r  e  n  t  s  c  r  e  e  n  s  w  i  t  h  a  s  i  g  n  i  f  i  c  a  n  t  o  v  e  r  l  a  p  i  n  r  e  s  p  o  n  s  e  t  o  I  R  R  a  n  d  e  t  o  p  o  s  i  d  e  .  I  n  t  e  r  e  s  t  i  n  g  l  y  ,  b  o  t  h  e  t  o  p  o  s  i  d  e  a  n  d  I  R  R  a  l  s  o  h  a  d  a  n  u  m  b  e  r  o  f  u  n  iu  e  m  o  d  u  l  a  t  o  r  s  o  f  N  F  -κ  B  a  c  t  i  v  i  t  y  .  A  s  t  r  i  k  i  n  g  o  b  s  e  r  v  a  t  i  o  n  w  a  s  t  h  e  l  a  r  g  e  d  i  s  p  a  r  i  t  y  i  n  t  h  e  h  i  t  s  i  d  e  n  t  i  f  i  e  d  f  r  o  m  s  i  R  N  A  s  t  a  r  g  e  t  i  n  g  t  h  e  s  a  m  e  g  e  n  e  s  b  e  t  w  e  e  n  b  o  t  h  v  e  n  d  o  r  s  p  l  a  t  f  o  r  m  s  ,  w  i  t  h  a  s  l  i  t  t  l  e  a  s  3  %  o  v  e  r  l  a  p  i  n  r  e  s  p  o  n  s  e  t  o  I  R  R  a  n  d M  e  t  h  o  d  1  C  e  l  l  l  i  n  e  s  a  n  d  c  u  l  t  u  r  e  c  o  n  d  i  t  i  o  n  s  :   I  n  o  r  d  e  r  t  ou  a  n  t  i  f  y  N  F  -κ  B  a  c  t  i  v  i  t  y  i  n  r  e  s  p  o  n  s  e  t  o  s  i  R  N  A  k  n  o  c  k  d  o  w  n  a  n  d  s  t  i  m  u  l  a  t  i  o  n  w  e  u  s  e  d  t  h  e  s  t  a  b  l  y  t  r  a  n  s  f  e  c  t  e  d  p  G  L  4  .  3  2  [  l  u  c  2  P  /  N  F  -κ  B  -R  E  /  H  y  g  r  o  (  P  r  o S M A R T p o o l o r f r o m I n v i t r o g e n : S c r a m b l e d : D h a r m a c o n O N T a r g e t p l u s N o n - T a r g e t t i n g p o o l D - 0 0 1 8 1 0 - 1 0 , R e l A : 2 p o o l e d c u s t o m s i R N A ; s i R N A 1 5 ' G C U G A U G U G C A C C G A C A A G , s i R N A 2 5 ' G C C C U A U C C C U U U A C G U C A ( E u r o g e n t e c ) . D h a r m a c o n O N T a r g e t p l u s S M A R T p o o l : R I P K 4 ( 5 4 1 0 1 ) L - 0 0 5 3 0 8 - 0 0 , J A K 2 ( 3 7 1 7 ) L - 0 0 3 1 4 6 - 0 0 , S R M S ( 6 7 2 5 ) L - 0 0 5 3 7 6 - 0 0 , P K I A ( 5 5 6 9 ) L - 0 1 2 3 2 1 - 0 0 , I R A K 3 ( 1 1 2 1 3 ) L - 0 0 4 7 6 2 - 0 0 , T N K 1 ( 8 7 1 1 ) L - 0 0 3 1 8 0 - 0 0 , M A P 3 K 1 0 ( 4 2 9 4 ) L - 0 0 3 5 7 6 - 0 0 . I n v i t r o g e n S t e a l t h s i R N A : R P S 6 K L ( H S S 1 3 0 3 0 3 ) , I K B K E ( H S S 1 1 4 4 1 0 ) . E x p e r i m e n t a l d a t a w e r e n o r m a l i s e d t o S c r a m b l e d s i R N A c o n t r o l s a n d b y c o n t r o l v a l u e s f o r t r e a t m e n t . N o r m a l i s e d v a l u e s w e r e t h e n s u b j e c t e d t o S t u d e n t ' s t t e s t s u s i n g P r i s m 6 ( G r a p h P a d ) . M e t h o d 7 s i R N A s c r e e n ad i n D a t a R e c o r d s 2 - 5 t o a l l o w f o r r o b u s t Z S c o r e c a l c u l a t i o n s f o r e a c h s i R N A s t u d i e d u n d e r e a c h c o n d i t i o n ( M e t h o d 7 ) . T h e d a t a r e c o r d i n c l u d e s : • s i R N A _ S c r e e n - S u p p l i e r f o r s i R N A s c r e e n • N o _ s i R N A - T o t a l n u m b e r o f s i R N A o n p l a t e • E x p e r i m e n t - S t i m u l a t i o n c o n d i t i o n s • P l a t e _ N o - E x p e r i m e n t a l p l a t e n u m b e r • R e p e a t _ N o - I n d e p e n d e n t b i o l o g i c a l r e p e a t • P l a t e _ M e d i a n - M e d i a n v a l u e o f a l l d a t a w i t h i n a n e x p e r i m e n t a l p l a t e a c r o s s b i o l o g i c a l r e p e a t s • P l a t e _ L o g 1 0 _ M e d i a n - L o g 1 0 t r a n s f o r m a t i o n o f P l a t e M e d i a n • P l a t e _ L o g 1 0 _ M A D - M e d i a n a b s o l u t e d e v i a t i o n o f p l a t e S u p p l e m e n t a l D a t a R e c o r d 2 - 3 D a t a R e c o r d 2 = R e f S e q A c c e s s i o n N u m b e r - D h a r m a c o n S c r e e n D a t a R e c o r d 3 = R e f S e q A c c e s s i o n N u m b e r - S i g m a S c r e e n R e f S e q A c c e s s i o n N u m b e r f o r D h a m a r c o n ( D a t a R e c o r d 2 ) a n d S i g m a ( D a t a R e c o r d 3 ) w i t h a s s o c i a t e d g e n e n a m e , p l a t e n u m b e r a n d w e l l p o s i t i o n . E a c h r e c o r d i s d e s i g n a t e d w i t h : • A c N u m b e r - s i R N A t a r g e t g e n e a c c e s s i o n n u m b e r i n R e f S e q f o r m a t • G e n e - G e n e n a m e a s s o c i a t e d w i t h s i R N A • P l a t e - P l a t e r e f e r e n c e n u m b e r • R o w - R o w n u m b e r c o - o r d i n a t e f o r s i R N A w i t h i n p l a t e • C o l u m n - C o l u m n n u m b e r c o - o r d i n a t e f o r s i R N A w i t h i n p l a tf o r N F - κ B a c t i v i t y ( r e l a t i v e l i g h t u n i t s ) , L o g 1 0 t r a n s f o r m a t i o n s a n d R o b u s t Z S c o r e c a l c u l a t i o n s f o r e a c h r e p e a t ( M e t h o d 7 ) . E a c h r e c o r d i s d e s i g n a t e d w i t h : • s i R N A - N a m e o f t h e g e n e t h e s i R N A i s t a r g e t i n g • P l a t e - S o u r c e p l a t e n u m b e r f r o m s i R N A l i b r a r y • C 1 - C 4 - R a w R L U v a l u e s f o r e a c h r e p e a t f o r c o n t r o l b i o l o g i c a l r e p l i c a t e s • T 1 - T 4 - R a w R L U v a l u e s f o r e a c h r e p e a t f o r s t i m u l u s b i o l o g i c a l r e p l i c a t e s • L o g 1 0 C 1 - L o g 1 0 C 4 - L o g 1 0 t r a n s f o r m a t i o n o f R L U v a l u e s f o r c o n t r o l b i o l o g i c a l r e p l i c a t e s • L o g 1 0 T 1 - L o g 1 0 T 4 - L o g 1 0 t r a n s f o r m a t i o n o f R L U v a l u e s f o r s t i m u l u s b i o l o g i c a l r e p l i c a t e s • Z C 1 - Z C 4 - R o b u s t Z s c o r e f of o r N F - κ B a c t i v i t y ( r e l a t i v e l i g h t u n i t s ) , L o g 1 0 t r a n s f o r m a t i o n s a n d R o b u s t Z S c o r e c a l c u l a t i o n s f o r e a c h r e p e a t ( M e t h o d 7 ) . E a c h r e c o r d i s d e s i g n a t e d w i t h : • s i R N A - N a m e o f t h e g e n e t h e s i R N A i s t a r g e t i n g • P l a t e - S o u r c e p l a t e n u m b e r f r o m s i R N A l i b r a r y • C 1 - C 4 ( C 1 - C 6 f o r D a t a R e c o r d 7 ) - R a w R L U v a l u e s f o r e a c h r e p e a t f o r c o n t r o l b i o l o g i c a l r e p l i c a t e s • T 1 - T 4 ( T 1 - T 6 f o r D a t a R e c o r d 7 ) - R a w R L U v a l u e s f o r e a c h r e p e a t f o r s t i m u l u s b i o l o g i c a l r e p l i c a t e s • L o g 1 0 C 1 - L o g 1 0 C 4 ( L o g 1 0 C 1 - L o g 1 0 C 6 f o r D a t a R e c o r d 7 ) - L o g 1 0 t r a n s f o r m a t i o n o f R L U v a l u e s f o r c o n t r o l b i o l o g i c a l r e p l i c a t e s • L o g 1 0 T 1 - L o g 1 0 T 4 ( L o g 1 0 T 1 - L o g 1 0 T 6 f o r D a t a R e c o r d 7 ) - L o g 1 0 t r a n s f o r m a t i o n o f R L U v a l u e s f o r s t i m u l u s b i o l o g i c a l r e p l i c a t e s • Z C 1 - Z C 4 ( Z C 1 - Z C 6 f o r D a t a R e c o r d 7 ) - R o b u s t Z s c o r e f o r e a c h r e p e a t f o r c o n t r o l b i o l o g i c a l r e p l i c a t e s • Z T 1 - Z T 4 ( Z T 1 - Z T 6 f o r D a t a R e c o r d 7 ) - R o b u s t Z s c o r e f o r e a c h r e p e a t f o r s t i m u l u s b i o l o g i c a l r e p l i c a t e s S u p p l e m e n t a l D a t a R e c o r d 8 - 9 D a t a R e c o r d 8 = N o r m a l i s e d D h a r m a c o n S c r e e n D a t a - E t o p o s i d e D a t a R e c o r d 9 = N o r m a l i s e d D h a r m a c o n S c r e e n D a t a - I o n i s i n g R a d i a t i o n C o m p i l e d n o r m a l i s e d s c r e e n d a t a c a l c u l a t e d u s i n g t h e R o b u s t Z S c o r e s f o r t h e N F - κ B r e p o T  -M  e  a  n  -M  e  a  n  s  t  i  m  u  l  u  s  R  o  b  u  s  t  Z  S  c  o  r  e  c  a  l  c  u  l  a  t  e  d  f  r  o  m  D  a  t  a  R  e  c  o  r  d  s  6  -7  •  C  -S  D  -S  t  a  n  d  a  r  d  d  e  v  i  a  t  i  o  n  o  f  c  o  n  t  r  o  l  R  o  b  u  s  t  Z  S  c  o  r  e  c  a  l  c  u  l  a  t  e  d  f  r  o  m  D  a  t  a  R  e  c  o  r  d  s  6  -7  •  T  -S  D  -S  t  a  n  d  a  r  d  d  e  v  i  a  t  i  o  n  o  f  s  t  i  m  u  l  u  s  R  o  b  u  s  t  Z  S  c  o  r  e  c  a  l  c  u  l  a  t  e  d  f  r  o  m  D  a  t  a  R  e  c  o  r  d  s O S , " N F - κ B U 2 O S " = N F - κ B r e p o r t e r U 2 O S ) • R a w 1 - R a w 4 - R a w R L U v a l u e s f r o m e x p e r i m e n t • L o g 1 0 - 1 - L o g 1 0 - 4 - L o g 1 0 t r a n s f o r m a t i o n o f r a w R L U v a l u e s • L o g 1 0 M e d i I  K  B  K  G  (  N  E  M  O  )  ,  a  k  n  o  w  n  r  eu  i  r  e  d  e  n  z  y  m  e  f  o  r  N  F  -κ  B  a  c  t  i  v  i  t  y  i  n  r  e  s  p  o  n  s  e  t  o  D  N  A  d  a  m  a  g  e   2   .  W  e  s  p  e  c  u  l  a  t  e  t  h  a  t  t  h  i  s  i  s  l  i  k  e  l  y  d  u  e  t  o  i  n  e  f  f  i  c  i  e  n  t  k  n  o  c  k  d  o  w  n  o  f  N  E  M  O  i  n  t  h  e  s  e  s  a  m  p  l  e  s  .  I  t  s  h  o  u  l  d  a  l  s  o  b  e  n  o  t  e  d  t  h  a  t  w  h  e  n  t  h  e  s  e  c  a  n  d  i  d  a  t  e  s  d  i  d  n  o  t  m  a  t  c  h  t  h  e  l  i  t  e  r  a  t  u  r  e  ,  n  o  e  f  f  e  c  t  w  a  s  o  b  s  e  r  v  e  d  i  n  t  h  e  s  c  r  e  e  n  .  T  h  e  S  i  g  m  a  s  c  r  e  e  n  r  e  p  l  i  c  a  t  e  d  t  h  e  l  i  t  e  r  a  t  u  r  e  i  n  4  /  7  c  a  s  e  s  f  o  r  b  o  t  h  e  t  o  p  o  s  i  d  e  a  n  d  I  R  R  t  r  e  a  t  m  e  n  t  s  .  O  n  e  n  o  t  a  b  l  e  r  e  s  u  l  t  w  a  s  t  h  a  t  C  H  U  K  (  I  K  K 
Figure Legends
clinical efficacy of IFN-γ -primed MSC as com et al. 19 . MSC genetically transfected with inter effect in vivo 20 . Bartosh, et al. reported that M TNF-α stimulated gene/protein 6 (TSG-6), st and CD82 21 . MSC engineered with budesonide IDO activity 22 . In particular, small molecule pr to treatment of large numbers of cells for clinic tion by utilizing limited selection of well-estab this study, we established a high-throughput s specifically enhance secretion of a candidate im been implicated as a key component of the MS to detect compounds that enhance PGE2 secr MSC from healthy donors. We titrated the cell for the screen. We found that incubating 1500 c best for cell metabolic activity and for measuri Table legend Summary table of validation results in comparison with screening results for selected siRNA. "No Change" highlights those siRNA that did not have an effect in the original screens. Given that most siRNA in these screens will have no effect on NFkB activity we suggest that this may be amore efficient way of considering validation efficiency.
No Change = No significant change, Decrease = Significant decrease, Increase = Significant increase. For small scale validation results, significance determined by Student's t-tests. For screening results robust Z score was used. An increase was considered >1.96, a decrease was considered <1.96. 
With "No Change" from screens excluded All data considered
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